Kumquat Biosciences
Scott Platshon joined Kumquat Biosciences as a Board Observer in August 2019. Since 2015, he has served as a principal at EcoR1 Capital, a fundamental biotechnology-focused investment firm in San Francisco. Prior to that, he was an analyst for Aquilo Partners, a boutique life-science investment bank. Scott holds a Bachelor of Science in Bioengineering from Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Kumquat Biosciences
Kumquat Biosciences’ vision is to develop innovative therapies to bring about sustainable and life-changing benefits to cancer patients. They are committed to translating breakthrough science to innovative medicines by combining internal expertise in drug discovery and development, with external collaboration with academics.